The pleiotropic effects of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in renal disease

References

• PignoneMPhillipsCMulrowCUse of lipid lowering drugs for primary prevention of coronary heart disease: meta-analysis of randomised trialsBMJ2000321726798398611039962
   PubMed Web of Science ®Google Scholar
• Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study GroupN Engl J Med199833919134913579841303
   PubMed Web of Science ®Google Scholar
• MihosCGSalasMJSantanaOThe pleiotropic effects of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in cardiovascular disease: a comprehensive reviewCardiol Rev201018629830420926939
   PubMed Web of Science ®Google Scholar
• MihosCGSantanaOPleiotropic effects of the HMG-CoA reductase inhibitorsInt J Gen Med2011426127121556312
   PubMedGoogle Scholar
• ClelandJGMcMurrayJJKjekshusJCORONA Study GroupPlasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: prediction of cardiovascular events and interaction with the effects of rosuvastatin: a report from CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure)J Am Coll Cardiol200954201850185919892235
   PubMed Web of Science ®Google Scholar
• BarriosVEscobarCRosuvastatin along the cardiovascular continuum: from JUPITER to AURORAExpert Rev Cardiovasc Ther20097111317132719900015
   PubMedGoogle Scholar
• DobeshPPKlepserDGMcGuireTRMorganCWOlsenKMReduction in mortality associated with statin therapy in patients with severe sepsisPharmacotherapy200929662163019476415
   PubMed Web of Science ®Google Scholar
• ZeichnerSMihosCGSantanaOThe pleiotropic effects and therapeutic potential of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in malignancies: a comprehensive reviewJ Cancer Res Ther20128217618322842358
   PubMed Web of Science ®Google Scholar
• YanuckDMihosCGSantanaOMechanisms and clinical evidence of the pleiotropic effects of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in central nervous system disorders: a comprehensive reviewInt J Neurosci20121221161962922720798
   PubMed Web of Science ®Google Scholar
• MihosCGArtolaRTSantanaOThe pleiotropic effects of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in rheumatologic disorders: a comprehensive reviewRheumatol Int201232228729421805349
   PubMed Web of Science ®Google Scholar
• LazzeriniPELorenziniSSelviESimvastatin inhibits cytokine production and nuclear factor-kB activation in interleukin 1beta-stimulated synoviocytes from rheumatoid arthritis patientsClin Exp Rheumatol200725569670018078616
   PubMed Web of Science ®Google Scholar
• TikizCUtukOPirildarTEffects of Angiotensin-converting enzyme inhibition and statin treatment on inflammatory markers and endothelial functions in patients with longterm rheumatoid arthritisJ Rheumatol200532112095210116265685
   PubMed Web of Science ®Google Scholar
• EndresMStatins and strokeJ Cereb Blood Flow Metab20052591093111015815580
   PubMed Web of Science ®Google Scholar
• LiaoJKBeyond lipid lowering: the role of statins in vascular protectionInt J Cardiol200286151812243846
   PubMed Web of Science ®Google Scholar
• LiJLiJJHeJGNanJLGuoYLXiongCMAtorvastatin decreases C-reactive protein-induced inflammatory response in pulmonary artery smooth muscle cells by inhibiting nuclear factor-kappaB pathwayCardiovasc Ther201028181420074254
   PubMed Web of Science ®Google Scholar
• IwataAShiraiRIshiiHInhibitory effect of statins on inflammatory cytokine production from human bronchial epithelial cellsClin Exp Immunol2012168223424022471285
   PubMed Web of Science ®Google Scholar
• LuzakBRywaniakJStanczykLWatalaCPravastatin and simvastatin improves acetylsalicylic acid-mediated in vitro blood platelet inhibitionEur J Clin Invest201242886487222409214
   PubMed Web of Science ®Google Scholar
• JinCHuCPolichnowskiAEffects of renal perfusion pressure on renal medullary hydrogen peroxide and nitric oxide productionHypertension20095361048105319433780
   PubMed Web of Science ®Google Scholar
• CowleyAWJrRenal medullary oxidative stress, pressure-natriuresis, and hypertensionHypertension200852577778618852392
   PubMed Web of Science ®Google Scholar
• ZhenJLuHWangXQVaziriNDZhouXJUpregulation of endothelial and inducible nitric oxide synthase expression by reactive oxygen speciesAm J Hypertens2008211283418091741
   PubMed Web of Science ®Google Scholar
• OttCSchlaichMPSchmidtBMTitzeSISchäufeleTSchmiederRERosuvastatin improves basal nitric oxide activity of the renal vasculature in patients with hypercholesterolemiaAtherosclerosis2008196270471117298834
   PubMed Web of Science ®Google Scholar
• RidkerPMDanielsonEFonsecaFAJUPITER Study GroupRosuvastatin to prevent vascular events in men and women with elevated C-reactive proteinN Engl J Med2008359212195220718997196
   PubMed Web of Science ®Google Scholar
• VidtDGRidkerPMMonyakJTSchreiberMJCressmanMDLongitudinal assessment of estimated glomerular filtration rate in apparently healthy adults: a post hoc analysis from the JUPITER study (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin)Clin Ther201133671772521704236
   PubMed Web of Science ®Google Scholar
• LaRosaJCGrundySMWatersDDTreating to New Targets (TNT) InvestigatorsIntensive lipid lowering with atorvastatin in patients with stable coronary diseaseN Engl J Med2005352141425143515755765
   PubMed Web of Science ®Google Scholar
• ShepherdJKasteleinJJBittnerVTreating to New Targets InvestigatorsEffect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) studyClin J Am Soc Nephrol2007261131113917942759
   PubMed Web of Science ®Google Scholar
• GuptaAKChangCLCollierBThe relationship between statin therapy and progression of renal damage among 10305 hypertensive patients randomised in the ASCOT-lipid-lowering arm (LLA)Atheroscl Suppl2011121158159
   Web of Science ®Google Scholar
• ViraniSSNambiVPolsaniVRPreoperative statin therapy decreases risk of postoperative renal insufficiencyCardiovasc Ther2010282808620398096
   PubMed Web of Science ®Google Scholar
• HuffmyerJLMauermannWJThieleRHMaJZNemergutECPreoperative statin administration is associated with lower mortality and decreased need for postoperative hemodialysis in patients undergoing coronary artery bypass graft surgeryJ Cardiothorac Vasc Anesth200923446847319157909
   PubMed Web of Science ®Google Scholar
• ProwleJRCalzavaccaPLicariEPilot double-blind, randomized controlled trial of short-term atorvastatin for prevention of acute kidney injury after cardiac surgeryNephrology (Carlton)201217321522422117606
   PubMed Web of Science ®Google Scholar
• ArgaliousMXuMSunZSmediraNKochCGPreoperative statin therapy is not associated with a reduced incidence of postoperative acute kidney injury after cardiac surgeryAnesth Analg2010111232433020375302
   PubMed Web of Science ®Google Scholar
• KraneVWannerCStatins, inflammation and kidney diseaseNat Rev Nephrol20117738539721629228
   PubMed Web of Science ®Google Scholar
• AbediniSHolmeIMärzWALERT study groupInflammation in renal transplantationClin J Am Soc Nephrol2009471246125419541816
   PubMed Web of Science ®Google Scholar
• HungAMCrawfordDCGriffinMRAASK Study GroupCRP polymorphisms and progression of chronic kidney disease in African AmericansClin J Am Soc Nephrol201051243319965533
   PubMed Web of Science ®Google Scholar
• EllerPEllerKWolfAMAtorvastatin attenuates murine anti-glomerular basement membrane glomerulonephritisKidney Int201077542843520016464
   PubMed Web of Science ®Google Scholar
• KostapanosMSLiberopoulosENElisafMSStatin pleiotropy against renal injuryJ Cardiometab Syndr200941E4E919245508
   PubMedGoogle Scholar
• AthyrosVGGanotakisEKolovouGDAssessing The Treatment Effect in Metabolic Syndrome Without Perceptible Diabetes (ATTEMPT) Collaborative. Assessing the treatment effect in metabolic syndrome without perceptible diabetes (ATTEMPT): a prospective- randomized study in middle aged men and womenCurr Vasc Pharmacol20119664765721476961
   PubMed Web of Science ®Google Scholar
• AthyrosVGKaragiannisAGanotakisESAssessing The Treatment Effect in Metabolic syndrome without Perceptible diabeTes (ATTEMPT) Collaborative Group. Association between the changes in renal function and serum uric acid levels during multifactorial intervention and clinical outcome in patients with metabolic syndrome. A post hoc analysis of the ATTEMPT studyCurr Med Res Opin20112781659166821714711
   PubMed Web of Science ®Google Scholar
• SandhuSWiebeNFriedLFTonelliMStatins for improving renal outcomes: a meta-analysisJ Am Soc Nephrol20061772006201616762986
   PubMed Web of Science ®Google Scholar
• NavaneethanSDPansiniFPerkovicVHMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysisCochrane Database Syst Rev2009CD00778419370693
   PubMed Web of Science ®Google Scholar
• BianchiSBigazziRCaiazzaACampeseVMA controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney diseaseAm J Kidney Dis200341356557012612979
   PubMed Web of Science ®Google Scholar
• AstraZenecaRandomized, double-blind, 52-wk, parallel-grp, multicentre, PIIb study to evaluate effects of rosuvastatin 10 mg, rosuvastatin 40 mg and atorvastatin 80 mg on urinary protein excretion in hypercholesterolaemic diabetic patients with moderate proteinuria NLM identifier: NCT00296374
   Google Scholar
• AstraZenecaRandomized, double-blind, 52-wk, parallel-grp multicentre, PIIb study to evaluate effects of rosuvastatin 10 mg, rosuvastatin 40 mg and atorvastatin 80 mg on urinary protein excretion in hypercholesterolaemic non-diabetic patients with moderate proteinuria NLM identifier: NCT00296400
   Google Scholar
• WuYWangYAnCEffects of rosuvastatin and atorvastatin on renal function: meta-analysisCirc J20127651259126622382383
   PubMed Web of Science ®Google Scholar
• Randomized, double-blind, parallel-grpAtorvastatin versus rosuvastatin on contrast induced acute kidney injury (PRATO-ACS 2) study NLM identifier: NCT01870804
   Google Scholar
• BaigentCLandrayMJReithCSHARP InvestigatorsThe effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trialLancet201137797842181219221663949
   PubMed Web of Science ®Google Scholar
• FassettRGRobertsonIKBallMJGeraghtyDPCoombesJSEffect of atorvastatin on kidney function in chronic kidney disease: a randomised double-blind placebo-controlled trialAtherosclerosis2010213121822420810109
   PubMed Web of Science ®Google Scholar
• ManskeCLSprafkaJMStronyJTWangYContrast nephropathy in azotemic diabetic patients undergoing coronary angiographyAm J Med19908956156202239981
   PubMed Web of Science ®Google Scholar
• BarrettBJContrast nephrotoxicityJ Am Soc Nephrol1994521251377993992
   PubMed Web of Science ®Google Scholar
• ParfreyPSGriffithsSMBarrettBJContrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled studyN Engl J Med198932031431492643041
   PubMed Web of Science ®Google Scholar
• MehranRAymongEDNikolskyEA simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validationJ Am Coll Cardiol20044471393139915464318
   PubMed Web of Science ®Google Scholar
• WeinrauchLAHealyRWLelandOSCoronary angiography and acute renal failure in diabetic azotemic nephropathyAnn Intern Med19778615659835928
   PubMed Web of Science ®Google Scholar
• KandzariDERebeizAGWangASketchMHContrast nephropathy: an evidence-based approach to preventionAm J Cardiovasc Drugs20033639540514728060
   PubMedGoogle Scholar
• PattiGRicottiniENuscaAShort-term, high-dose atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage during angioplasty – contrast-induced nephropathy] trialAm J Cardiol201110811721529740
   PubMed Web of Science ®Google Scholar
• KhanalSAttallahNSmithDEStatin therapy reduces contrast-induced nephropathy: an analysis of contemporary percutaneous interventionsAm J Med2005118884384916084176
   PubMed Web of Science ®Google Scholar
• ZhangLZhangLLuYEfficacy of statin pretreatment for the prevention of contrast-induced nephropathy: a meta-analysis of randomised controlled trialsInt J Clin Pract201165562463021489086
   PubMed Web of Science ®Google Scholar
• PappyRStavrakisSHennebryTAAbu-FadelMSEffect of statin therapy on contrast-induced nephropathy after coronary angiography: a meta-analysisInt J Cardiol2011151334835321636154
   PubMed Web of Science ®Google Scholar
• TodorovicZNesicZStojanovićRAcute protective effects of simvastatin in the rat model of renal ischemia-reperfusion injury: it is never too late for the pretreatmentJ Pharmacol Sci2008107446547018719319
   PubMed Web of Science ®Google Scholar
• HoldaasHFellströmBJardineAGAssessment of LEscol in Renal Transplantation (ALERT) Study InvestigatorsEffect of fluvastatin in cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trialLancet200336193742024203112814712
   PubMed Web of Science ®Google Scholar
• PalmerSCNavaneethanSDCraigJCHMG CoA reductase inhibitors (statins) for kidney transplant recipientsCochrane Database Syst Rev20141CD00501924470059
   PubMed Web of Science ®Google Scholar
• ReilingJJohnsonDWKrugerPSPillansPWallDRAssociation of pre-transplant statin use with delayed graft function in kidney transplant recipientsBMC Nephrol20121311122985048
   PubMed Web of Science ®Google Scholar
• Randomized, double-blind, parallel-grp, anti-inflammatory and renoprotective effect of pretreatment loading dose atorvastatin in coronary artery bypass graft surgery NLM identifier: NCT01547455
   Google Scholar
• Randomized, double-blind, parallel-grpShort-term atorvastatin’s effect on acute kidney injury following cardiac surgery NLM identifier: NCT00791648
   Google Scholar
• Randomized, double-blind, parallel-grpPreventive effect of the pretreatment with pitavastatin on contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography/intervention (PRINCIPLE-II) study NLM identifier: NCT 01871792
   Google Scholar
• Randomized, double-blind, parallel-grpStudy of atorvastatin dose dependent reduction of proteinuria(SARP) study NLM identifier: NCT 00768638
   Google Scholar
• Randomized, double-blind, parallel-grpEfficacy of statins in prevention of contrast-induced nephropathy(SCIN) study NLM identifier: NCT 01071993
   Google Scholar